Patent ID: 8658377

Claim:
A method for diagnosing ovarian cancer in a subject, comprising: contacting, an ovarian tissue sample obtained from said subject with one or more antibodies that bind specifically to CCL25 or CCR9 or both CCL25 and CCR9; measuring the level(s) of expression of CCL25 and/or CCR9 based on their interactions with said one or more antibodies in said ovarian tissue sample; and comparing the level of expression of CCL25 and/or CCR9 in said ovarian tissue sample to a normal level of expression of said one or more cancer markers, wherein a higher than normal level of expression of CCL25 and/or CCR9 in said ovarian tissue sample is indicative of the presence of ovarian cancer in said subject, and wherein said normal level of expression of CCL25 and/or CCR9 is a predetermined value or is obtained from a control sample of known normal non-cancerous ovarian cells of the same origin or type as said ovarian tissue sample.